-
Je něco špatně v tomto záznamu ?
Development of IFN-gamma resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells
M Fojtova, V Boudny, A Kovarik, L Lauerova, L Adamkova, K Souckova, J Jarkovsky, J Kovarik
Jazyk angličtina Země Velká Británie
Grantová podpora
NR8341
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
NLK
Free Medical Journals
od 1947 do Před 1 rokem
Freely Accessible Journals
od 1947 do Před 1 rokem
PubMed Central
od 1947 do Před 1 rokem
Europe PubMed Central
od 1947 do Před 1 rokem
ProQuest Central
od 2000-01-01 do 2017-12-31
Open Access Digital Library
od 1947-01-01
Open Access Digital Library
od 1999-01-01
Medline Complete (EBSCOhost)
od 1999-01-01 do 2015-11-17
Nursing & Allied Health Database (ProQuest)
od 2000-01-01 do 2017-12-31
Health & Medicine (ProQuest)
od 2000-01-01 do 2017-12-31
Public Health Database (ProQuest)
od 2000-01-01 do 2017-12-31
PubMed
17579625
DOI
10.1038/sj.bjc.6603849
Knihovny.cz E-zdroje
- MeSH
- chemorezistence genetika MeSH
- exprese genu MeSH
- financování organizované MeSH
- fosforylace MeSH
- interferon gama farmakologie terapeutické užití MeSH
- lidé MeSH
- melanom farmakoterapie genetika MeSH
- nádorové buněčné linie MeSH
- nádory kůže farmakoterapie genetika MeSH
- proliferace buněk účinky léků MeSH
- proteiny SOCS genetika MeSH
- regulace genové exprese u nádorů MeSH
- stanovení celkové genové exprese MeSH
- transkripční faktor STAT1 metabolismus MeSH
- Check Tag
- lidé MeSH
The resistance to interferons (IFNs) limits their anticancer therapeutic efficacy. Here we studied the evolution of an IFN-resistant state in vitro using melanoma cell lines. We found that the cells became less sensitive to antiproliferative effect of IFN-gamma after prolonged cultivation enabling us to isolate sensitive and resistant subclones of the parental line. We investigated transcription of signal transducer and activator of transcription (STAT) 1-6 and suppressor of cytokine signalling (SOCS) 1-3 genes, and phosphorylation of STAT 1 protein. The resistant subline (termed WM 1158R) differed from the sensitive subline (WM 1158S) by a constitutive expression of SOCS 3, lack or weak SOCS 1-3 activation following IFN-gamma, and short duration of cytokine activatory signal. Similar correlations were observed in additional melanoma lines differing in IFN sensitivities. At the protein level, IFN-gamma induced strong and prolonged STAT 1 activation at serine 727 (S727) in WM 1158R while in WM 1158S cells phosphorylation of this amino acid was much less pronounced. On the other hand, phosphorylation of tyrosine 701 (Y701) was stimulated regardless of the sensitivity phenotype. In conclusion, constitutive expression of SOCS 3 is correlated with attenuation of its induction following IFN treatment. These results suggest that progression of melanoma cells from IFN sensitivity to IFN insensitivity associates with changes in SOCS expression.
Citace poskytuje Crossref.org
- 000
- 03411naa 2200481 a 4500
- 001
- bmc10010229
- 003
- CZ-PrNML
- 005
- 20140312090958.0
- 008
- 100429s2007 xxk e eng||
- 009
- AR
- 024 __
- $a 10.1038/sj.bjc.6603849 $2 doi
- 035 __
- $a (PubMed)17579625
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Fojtová, Miloslava. $7 _AN031165
- 245 10
- $a Development of IFN-gamma resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells / $c M Fojtova, V Boudny, A Kovarik, L Lauerova, L Adamkova, K Souckova, J Jarkovsky, J Kovarik
- 314 __
- $a Institute of Biophysics, Academy of Sciences of the Czech Republic v.v.i., Kralovopolska 135, 612 65 Brno, Czech Republic.
- 520 9_
- $a The resistance to interferons (IFNs) limits their anticancer therapeutic efficacy. Here we studied the evolution of an IFN-resistant state in vitro using melanoma cell lines. We found that the cells became less sensitive to antiproliferative effect of IFN-gamma after prolonged cultivation enabling us to isolate sensitive and resistant subclones of the parental line. We investigated transcription of signal transducer and activator of transcription (STAT) 1-6 and suppressor of cytokine signalling (SOCS) 1-3 genes, and phosphorylation of STAT 1 protein. The resistant subline (termed WM 1158R) differed from the sensitive subline (WM 1158S) by a constitutive expression of SOCS 3, lack or weak SOCS 1-3 activation following IFN-gamma, and short duration of cytokine activatory signal. Similar correlations were observed in additional melanoma lines differing in IFN sensitivities. At the protein level, IFN-gamma induced strong and prolonged STAT 1 activation at serine 727 (S727) in WM 1158R while in WM 1158S cells phosphorylation of this amino acid was much less pronounced. On the other hand, phosphorylation of tyrosine 701 (Y701) was stimulated regardless of the sensitivity phenotype. In conclusion, constitutive expression of SOCS 3 is correlated with attenuation of its induction following IFN treatment. These results suggest that progression of melanoma cells from IFN sensitivity to IFN insensitivity associates with changes in SOCS expression.
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a chemorezistence $x genetika $7 D019008
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a stanovení celkové genové exprese $7 D020869
- 650 _2
- $a regulace genové exprese u nádorů $7 D015972
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a interferon gama $x farmakologie $x terapeutické užití $7 D007371
- 650 _2
- $a melanom $x farmakoterapie $x genetika $7 D008545
- 650 _2
- $a fosforylace $7 D010766
- 650 _2
- $a transkripční faktor STAT1 $x metabolismus $7 D050794
- 650 _2
- $a nádory kůže $x farmakoterapie $x genetika $7 D012878
- 650 _2
- $a proteiny SOCS $x genetika $7 D050826
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Boudný, Vladimír $7 xx0061133
- 700 1_
- $a Kovařík, Aleš, $d 1960- $7 xx0028286
- 700 1_
- $a Lauerová, Ludmila $7 xx0061135
- 700 1_
- $a Adámková, Lenka $7 xx0061136
- 700 1_
- $a Součková, Kamila $7 xx0115676
- 700 1_
- $a Jarkovský, Jiří $7 stk2008461294
- 700 1_
- $a Kovařík, Jan $7 xx0061134
- 773 0_
- $t British Journal of Cancer $w MED00009369 $g Roč. 97, č. 2 (2007), s. 231-237 $x 0007-0920
- 910 __
- $a ABA008 $b x $y 8 $z 0
- 990 __
- $a 20100520111438 $b ABA008
- 991 __
- $a 20140312091007 $b ABA008
- 999 __
- $a ok $b bmc $g 724089 $s 587223
- BAS __
- $a 3
- BMC __
- $a 2007 $b 97 $c 2 $d 231-237 $i 0007-0920 $m British journal of cancer $n Br J Cancer $x MED00009369
- GRA __
- $a NR8341 $p MZ0
- LZP __
- $a 2010-B2/dkme